Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giuseppe Reimondo

Showing results (21-30 of 78) with videos related to

Pageof 8
Sort By:
Clinical Endocrinology|June 6, 2007
Screening of Cushing's syndrome in adult patients with newly diagnosed diabetes mellitusGiuseppe Reimondo, Anna Pia, Barbara Allasino, et al.
Cancers|September 17, 2020
Unwanted Hormonal and Metabolic Effects of Postoperative Adjuvant Mitotane Treatment for Adrenocortical CancerVittoria Basile, Soraya Puglisi, Anna Calabrese, et al.
Clinical Endocrinology|June 5, 2003
The corticotrophin-releasing hormone test is the most reliable noninvasive method to differentiate pituitary from ectopic ACTH secretion in Cushing's syndromeGiuseppe Reimondo, Piero Paccotti, Marco Minetto, et al.
Cancers|November 13, 2021
Molecular Mechanisms of Mitotane Action in Adrenocortical Cancer Based on In Vitro StudiesMarco Lo Iacono, Soraya Puglisi, Paola Perotti, et al.
Life (Basel, Switzerland)|April 3, 2021
Sex Differences on Mitotane Concentration and Treatment Outcome in Patients with Adrenocortical CarcinomaSarah Allegra, Soraya Puglisi, Irene Brescia, et al.
Biomedicines|August 26, 2022
Sex-Based Evaluation of Lipid Profile in Postoperative Adjuvant Mitotane Treatment for Adrenocortical CarcinomaSarah Allegra, Soraya Puglisi, Chiara Borin, et al.
The Journal of Clinical Endocrinology and Metabolism|January 5, 2020
Adrenal Incidentalomas are Tied to Increased Risk of Diabetes: Findings from a Prospective StudyGiuseppe Reimondo, Elena Castellano, Maurizio Grosso, et al.
Endocrine, Metabolic & Immune Disorders Drug Targets|September 24, 2019
Prolonged Adrenal Insufficiency After the Discontinuation of Mitotane TherapyLeonardo Muratori, Anna Pia, Giuseppe Reimondo, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|December 7, 2007
Laboratory differentiation of Cushing's syndromeGiuseppe Reimondo, Anna Pia, Silvia Bovio, et al.
International Journal of Endocrinology|June 16, 2015
Evaluation of Midnight Salivary Cortisol as a Predictor Factor for Common Carotid Arteries Intima Media Thickness in Patients with Clinically Inapparent Adrenal AdenomasGiuseppe Reimondo, Barbara Allasino, Marcella Coletta, et al.
Pageof 8

Showing results (21-30 of 78) with videos related to

Sort By:
Pageof 8
Clinical Endocrinology|June 6, 2007
Screening of Cushing's syndrome in adult patients with newly diagnosed diabetes mellitusGiuseppe Reimondo, Anna Pia, Barbara Allasino, et al.
Cancers|September 17, 2020
Unwanted Hormonal and Metabolic Effects of Postoperative Adjuvant Mitotane Treatment for Adrenocortical CancerVittoria Basile, Soraya Puglisi, Anna Calabrese, et al.
Clinical Endocrinology|June 5, 2003
The corticotrophin-releasing hormone test is the most reliable noninvasive method to differentiate pituitary from ectopic ACTH secretion in Cushing's syndromeGiuseppe Reimondo, Piero Paccotti, Marco Minetto, et al.
Cancers|November 13, 2021
Molecular Mechanisms of Mitotane Action in Adrenocortical Cancer Based on In Vitro StudiesMarco Lo Iacono, Soraya Puglisi, Paola Perotti, et al.
Life (Basel, Switzerland)|April 3, 2021
Sex Differences on Mitotane Concentration and Treatment Outcome in Patients with Adrenocortical CarcinomaSarah Allegra, Soraya Puglisi, Irene Brescia, et al.
Biomedicines|August 26, 2022
Sex-Based Evaluation of Lipid Profile in Postoperative Adjuvant Mitotane Treatment for Adrenocortical CarcinomaSarah Allegra, Soraya Puglisi, Chiara Borin, et al.
The Journal of Clinical Endocrinology and Metabolism|January 5, 2020
Adrenal Incidentalomas are Tied to Increased Risk of Diabetes: Findings from a Prospective StudyGiuseppe Reimondo, Elena Castellano, Maurizio Grosso, et al.
Endocrine, Metabolic & Immune Disorders Drug Targets|September 24, 2019
Prolonged Adrenal Insufficiency After the Discontinuation of Mitotane TherapyLeonardo Muratori, Anna Pia, Giuseppe Reimondo, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|December 7, 2007
Laboratory differentiation of Cushing's syndromeGiuseppe Reimondo, Anna Pia, Silvia Bovio, et al.
International Journal of Endocrinology|June 16, 2015
Evaluation of Midnight Salivary Cortisol as a Predictor Factor for Common Carotid Arteries Intima Media Thickness in Patients with Clinically Inapparent Adrenal AdenomasGiuseppe Reimondo, Barbara Allasino, Marcella Coletta, et al.
Pageof 8